APA (7th ed.) Citation

XY, H., F, W., XG, S., MZ, G., JN, W., CH, X., . . . XM, M. (2023). Compound-42 alleviates acute kidney injury by targeting RIPK3-mediated necroptosis. British journal of pharmacology, 180(20), 2641. https://doi.org/10.1111/bph.16152

Chicago Style (17th ed.) Citation

XY, He, et al. "Compound-42 Alleviates Acute Kidney Injury by Targeting RIPK3-mediated Necroptosis." British Journal of Pharmacology 180, no. 20 (2023): 2641. https://doi.org/10.1111/bph.16152.

MLA (9th ed.) Citation

XY, He, et al. "Compound-42 Alleviates Acute Kidney Injury by Targeting RIPK3-mediated Necroptosis." British Journal of Pharmacology, vol. 180, no. 20, 2023, p. 2641, https://doi.org/10.1111/bph.16152.